NCT06975085View on ClinicalTrials.gov

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study

PHASE2CompletedINTERVENTIONAL

Enrollment

781

Participants

Timeline

Start Date

April 16, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Breast Cancer Female

Interventions

BEHAVIORAL

Presentation of a personal breast cancer risk estimate

Participants answer questions that are used to calculate their personal breast cancer risk using the Gail Model. This risk estimate is presented to participants using written text and an icon array.

Trial Locations (1)

80045

University of Colorado, Aurora

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER